Cardiovascular and mortality outcomes with GLP‑1 receptor agonists vs other glucose‑lowering drugs in individuals with NAFLD and type 2 diabetes: a large population‑based matched cohort study
Krishnan A, et al. Diabetologia. 2024. 67:483–493. DOI: 10.1007/s00125-023-06057-5
Abstrak
(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)